Literature DB >> 2163984

Hepatic diseases in the elderly.

J Van Dam1, J B Zeldis.   

Abstract

The clinical manifestations of liver disease in the geriatric population reflect both the cumulative effects of longevity on the liver and the generalized senescence of the body's ability to adjust to metabolic, infectious, and immunologic insults. Although liver tests are not significantly affected by age, the presentation of liver diseases such as viral hepatitis may be more subtle in the geriatric population than that of younger patients. Alcoholic liver disease and primary biliary cirrhosis usually are advanced in the elderly. Geriatric patients are at risk for untoward drug side effects because of polypharmacy, alterations in the rate of first pass and phase I metabolism, and decreased capacity of carrier proteins such as albumin.

Entities:  

Mesh:

Year:  1990        PMID: 2163984

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  3 in total

Review 1.  Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals.

Authors:  Gary Ginsberg; Dale Hattis; Abel Russ; Babasaheb Sonawane
Journal:  Environ Health Perspect       Date:  2005-09       Impact factor: 9.031

2.  Therapeutic effects of atorvastatin and ezetimibe compared with double-dose atorvastatin in very elderly patients with acute coronary syndrome.

Authors:  Zhi Liu; Hengjian Hao; Chunlin Yin; Yanyan Chu; Jing Li; Dong Xu
Journal:  Oncotarget       Date:  2017-06-20

3.  The risk factors and predictive nomogram of human albumin infusion during the perioperative period of posterior lumbar interbody fusion: a study based on 2015-2020 data from a local hospital.

Authors:  Bo Liu; Junpeng Pan; Hui Zong; Zhijie Wang
Journal:  J Orthop Surg Res       Date:  2021-10-30       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.